Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health operating margin
Operating margin is operating income as a percentage of revenue.
Aspira Women's Health's operating margin for the twelve months ending Jun 30, 2026 was -4059.4%. For fiscal 2025 it was -2307.0%, against -406950.0% the year before. The highest annual figure on record is -21.7% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2307.0% | +404643.0 |
| FY2024 | Dec 31, 2024 | -406950.0% | −406928.3 |
| FY2023 | Dec 31, 2023 | -21.7% | +358.8 |
| FY2022 | Dec 31, 2022 | -380.5% | +98.0 |
| FY2021 | Dec 31, 2021 | -478.5% | −91.9 |
| FY2020 | Dec 31, 2020 | -386.6% | −49.9 |
| FY2019 | Dec 31, 2019 | -336.7% | +34.5 |
| FY2018 | Dec 31, 2018 | -371.2% | −36.7 |
| FY2017 | Dec 31, 2017 | -334.5% | +231.5 |
| FY2016 | Dec 31, 2016 | -566.0% | +318.2 |
| FY2015 | Dec 31, 2015 | -884.2% | −122.2 |
| FY2014 | Dec 31, 2014 | -762.0% | −416.6 |
| FY2013 | Dec 31, 2013 | -345.4% | +104.2 |
| FY2012 | Dec 31, 2012 | -449.6% | +467.8 |
| FY2011 | Dec 31, 2011 | -917.4% | +325.4 |
| FY2010 | Dec 31, 2010 | -1242.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -10794.1% | −9723.1 |
| Q1 FY2026 | Mar 31, 2026 | -6884.4% | −6718.5 |
| Q4 FY2025 | Dec 31, 2025 | -4012.5% | −3831.2 |
| Q3 FY2025 | Sep 30, 2025 | -1774.2% | −1555.4 |
| Q2 FY2025 | Jun 30, 2025 | -1071.0% | −1065.8 |
| Q3 FY2024 | Sep 30, 2024 | -165.9% | +19.8 |
| Q2 FY2024 | Jun 30, 2024 | -181.3% | −7.8 |
| Q1 FY2024 | Mar 31, 2024 | -218.8% | +52.4 |
| Q4 FY2023 | Dec 31, 2023 | -5.2% | +231.3 |
| Q3 FY2023 | Sep 30, 2023 | -185.7% | +228.4 |
| Q2 FY2023 | Jun 30, 2023 | -173.5% | +224.4 |
| Q1 FY2023 | Mar 31, 2023 | -271.2% | +217.3 |
| Q4 FY2022 | Dec 31, 2022 | -236.5% | +246.8 |
| Q3 FY2022 | Sep 30, 2022 | -414.1% | +167.6 |
| Q2 FY2022 | Jun 30, 2022 | -397.9% | +50.8 |
| Q1 FY2022 | Mar 31, 2022 | -488.5% | −95.0 |
| Q4 FY2021 | Dec 31, 2021 | -483.3% | −63.3 |
| Q3 FY2021 | Sep 30, 2021 | -581.7% | −236.2 |
| Q2 FY2021 | Jun 30, 2021 | -448.7% | +64.2 |
| Q1 FY2021 | Mar 31, 2021 | -393.4% | −82.0 |
| Q4 FY2020 | Dec 31, 2020 | -420.1% | −159.8 |
| Q3 FY2020 | Sep 30, 2020 | -345.5% | −45.9 |
| Q2 FY2020 | Jun 30, 2020 | -512.9% | −135.9 |
| Q1 FY2020 | Mar 31, 2020 | -311.5% | +151.7 |
| Q4 FY2019 | Dec 31, 2019 | -260.2% | +46.0 |
| Q3 FY2019 | Sep 30, 2019 | -299.6% | +41.9 |
| Q2 FY2019 | Jun 30, 2019 | -377.0% | +51.1 |
| Q1 FY2019 | Mar 31, 2019 | -463.1% | −26.3 |
| Q4 FY2018 | Dec 31, 2018 | -306.3% | +62.1 |
| Q3 FY2018 | Sep 30, 2018 | -341.5% | +16.0 |
| Q2 FY2018 | Jun 30, 2018 | -428.1% | −166.9 |
| Q1 FY2018 | Mar 31, 2018 | -436.8% | −71.0 |
| Q4 FY2017 | Dec 31, 2017 | -368.4% | −16.6 |
| Q3 FY2017 | Sep 30, 2017 | -357.5% | +198.7 |
| Q2 FY2017 | Jun 30, 2017 | -261.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -365.8% | – |
| Q4 FY2016 | Dec 31, 2016 | -351.8% | – |
| Q3 FY2016 | Sep 30, 2016 | -556.2% | – |
See a number that looks wrong?